KFSHRC CEO Dr. Majid Al Fayyadh Advocates For Healthcare As Strategic Investment At C3 Japan Summit

Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSHRC), addressed the C3 Davos of Healthcare Summit in Tokyo. He emphasised the urgent need for nations to view healthcare as an investment in collective security due to global health challenges like chronic diseases and climate change-driven illnesses.

Al Fayyadh highlighted that historical medical breakthroughs, such as vaccines and surgeries, relied on robust delivery systems and infrastructure. He stressed that modern innovations in robotics, biotechnology, and genomics require similar support to succeed.

Saudi Arabia's Vision 2030 Health Sector Transformation Program aims to shift healthcare from a public expense to a catalyst for innovation and economic growth. KFSHRC plays a key role in this transformation by achieving milestones like the first fully robotic heart transplant and pioneering CAR T-cell therapy.

KFSHRC was established over 50 years ago to reduce dependence on overseas treatment. Today, it leads advancements in genomic research, gene and cell therapy, regenerative medicine, and sustainable care models.

Al Fayyadh invited Japanese stakeholders and global partners to collaborate with Saudi Arabia in co-developing research, sharing technologies, and shaping integrated healthcare's future. The summit underscored the Kingdom’s openness to investments and partnerships that drive innovation for humanity's benefit.

In his closing remarks, Al Fayyadh stated: "The future of healthcare will be defined by integration, modernization, and collaboration. By redefining healthcare as an investment, we are building not only resilient national systems but also a stronger and healthier global community."

With inputs from SPA